IOLCP

Ibuprofen API

Ibuprofen API

ACTIVE PHARMACEUTICAL INGREDIENTS

“The Ibuprofen market holds significant growth potential and IOL is strategically expanding its value-added services in the Ibuprofen segment.”

Going up the value chain through IBU-derivatives

What is Ibuprofen?

Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID category belonging to а group of propionic acid derivatives. It is most commonly used for treating medical issues such as pain, fever, and inflammation. The global Ibuprofen market is expected to record a steady growth over the forthcoming years backed by various factors driving growth in this market such as high bioavailability with rapid action, increasing diseases and rising awareness about the drug and its effectiveness.Looking at its many advantages, IOL is strategically expanding its value-added services for its flagship product – Ibuprofen. IOL has commissioned a separate facility to manufacture these derivatives of Ibuprofen with a peak capacity of 500 MT per annum (expandable to 800 MTPA). Furthermore, with its strategy to enter the Japanese market, IOL has also developed a process for meeting Japanese Pharmacopeia specifications, which will now be manufactured in Ibu-derivative facility.